Palliser Capital urges break-up of UK defence group Chemring
Palliser Capital is calling for a break-up of UK defence group Chemring, arguing it has failed to capitalise on rising European military spending, according to a Financial Times report cited by Hedgeweek. The London-based firm, led by James Smith, has built a stake of approximately 3% and is urging a strategic review, including a possible sale of subsidiary Roke. Palliser estimates Roke could be worth between £600m and £730m as a standalone business.
Why “Unverified”
- Reported by Hedgeweek alone, with no second source or primary confirmation yet
1 independent source group across 1 post · evidence score 48/100. How labels work
What the sources claim
-
Palliser Capital is calling for a break-up of Chemring, arguing the company has failed to capitalise on rising European military spending.
“Palliser Capital is calling for a break-up of UK defence group Chemring, arguing that the company has failed to capitalise on rising European military spending”
Hedgeweek -
Palliser has accumulated a stake of approximately 3% in Chemring.
“has accumulated a stake of approximately 3% in Chemring”
Hedgeweek -
Palliser is urging the board to undertake a strategic review, including a potential sale of Roke.
“is urging the board to undertake a strategic review, including a potential sale of its electronic warfare and defence engineering subsidiary Roke”
Hedgeweek -
Palliser estimates Roke could be worth between £600m and £730m as a standalone business.
“Palliser estimates that Roke could be worth between £600m and £730m as a standalone business”
Hedgeweek
Sources
More in Hedge Funds
Embed this page
Summary and claims extracted by AI with prompt analyze-story@5 on 2026-11-19 10:20 UTC. Labels are computed from the sources, not by the model.